This study is for people with bladder cancer, including muscle invasive bladder cancer, who are having surgery called a radical cystectomy. This surgery removes the bladder and is the standard treatment for muscle invasive bladder cancer. After this surgery, some people experience complications like dehydration. This study wants to find out if giving intravenous fluids (IVF) at home after surgery can help prevent these complications and reduce hospital readmissions. You would be randomly assigned to either receive 1 liter of lactated ringers or normal saline through an IV three times a week for four weeks at home with a nurse, or to receive standard care without these home IV fluids. The main goal is to see how many people are readmitted to the hospital within 90 days after surgery. To join, you must be over 18, have confirmed bladder cancer, and be planning to have a radical cystectomy. The study's current status is unclear, and it plans to enroll 130 participants.

Study design

This is an interventional study that will randomly assign 130 participants to one of two groups. One group will receive home intravenous fluids, and the other will receive standard care.

What's involved

If you are in the home IVF group, you will receive 1 liter of intravenous fluids three times a week for four weeks with a home nurse. If you do not have existing vascular access, you will not receive a midline catheter.

Compensation

Not stated in the trial record.

Follow-up

The study will measure hospital readmission rates for up to 90 days after your surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.